SIIOS in Alaska: Testing an "In-Vault" Option for a Europa Lander Seismometer Experiment

The icy moons of Europa and Enceladus are thought to have global subsurface oceans in contact with mineral-rich silicate interiors, likely providing the three ingredients needed for life as we know it: liquid water, essential chemicals, and a source of energy. The possibility of life forming in their subsurface oceans relies in part on transfer of oxidants from the irradiated ice surface to the sheltered ocean below. Constraining the mechanisms and location of material exchange between the ice surface, the ice shell, and the subsurface ocean, however, is not possible without knowledge of ice thickness and liquid water depths. In a future lander-based experiment seismic measurements will be a key geophysical tool for obtaining this critical knowledge. The Seismometer to Investigate Ice and Ocean Structure (SIIOS) field-tests flight-ready technologies and develops the analytical methods necessary to make a seismic study of Europa and Enceladus a reality. We have been performing small-array seismology with a flight-candidate sensor in analog environments that exploit passive sources. Determining the depth to a subsurface ocean and any intermediate bodies of water is a priority for Ocean Worlds missions as it allows assessment of the habitability of these worlds and provides vital information for evaluating the spacecraft technologies required to access their oceans

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

The Deployment of the Seismometer to Investigate Ice and Ocean Structure (SIIOS) in Northwest Greenland: An experiment to study icy ocean world seismic deployments

In anticipation of future spacecraft missions to icy ocean worlds, the Seismometer to Investigate Ice and Ocean Structure (SIIOS) was funded by NASA to prepare for seismologic investigations of these worlds. During the summer of 2018, the SIIOS team deployed a seismic experiment on the Greenland Ice Sheet situated approximately 80 km north of Qaanaaq, Greenland. The deployment included one Trillium 120 s Posthole (TPH) broadband seismometer, thirteen Silicon Audio flight-candidate seismometers, five Sercel L28 4.5 Hz geophones, and one HTI 60-min hydrophone. Seismometers were buried 1 m deep in the firn in a cross-shaped array centered on a co-located TPH, hydrophone, and Silicon Audio instrument. One part of the array consisted of Silicon Audio and Sercel Geophones situated 1 m from the center of the array in the ordinal directions. A second set of four Silicon Audio instruments situated 1 km from the center of the array, in the cardinal directions. A mock-lander spacecraft was placed at the array center and instrumented with four Silicon Audio seismometers. We performed an active-source experiment and a passive-listening experiment that lasted for approximately 12 days. The active-source experiment consisted of 9-12 sledgehammer strikes to an aluminum plate at ten separate locations up to 100 m from the array center. The passive experiment recorded the ice-sheet ambient background noise, as well as local and regional events. Both datasets will be used to quantify differences in spacecraft instrumentation deployment strategies and for evaluating science capabilities for single-station and small-aperture seismic arrays in future geophysical missions. Our initial results indicate that the flight-candidate seismometer performs comparably to the TPH at frequencies above 0.1 Hz and that instruments coupled to the mock-lander perform comparably to ground-based instrumentation in the frequency band of 0.01-10 Hz. For future icy ocean world missions, a deck-coupled seismometer would perform similarly to a ground-based deployment.NASA PSTAR Grant #80NSSC17K0229 and NASA NESSF # 80NSSC18K126

Particle Size-Frequency Distributions of the OSIRIS-REx Candidate Sample Sites on Asteroid (101955) Bennu

International audienceWe manually mapped particles ranging in longest axis from 0.3 cm to 95 m on (101955) Bennu for the Origins, Spectral Interpretation, Resource Identification, and Security–Regolith Explorer (OSIRIS-REx) asteroid sample return mission. This enabled the mission to identify candidate sample collection sites and shed light on the processes that have shaped the surface of this rubble-pile asteroid. Building on a global survey of particles, we used higher-resolution data from regional observations to calculate particle size-frequency distributions (PSFDs) and assess the viability of four candidate sites for sample collection (presence of unobstructed particles ≤ 2 cm). The four candidate sites have common characteristics: each is situated within a crater with a relative abundance of sampleable material. Their PSFDs, however, indicate that each site has experienced different geologic processing. The PSFD power-law slopes range from −3.0 ± 0.2 to −2.3 ± 0.1 across the four sites, based on images with a 0.01-m pixel scale. These values are consistent with, or shallower than, the global survey measurements. At one site, Osprey, the particle packing density appears to reach geometric saturation. We evaluate the uncertainty in these measurements and discuss their implications for other remotely sensed and mapped particles, and their importance to OSIRIS-REx sampling operations